Transduced pep-1-fk506bp inhibits the inflammatory response in the raw 264.7 cell and mouse models

Immunobiology

Volumn 216, Issue 7, 2011, Pages 771-781

  Kim, So Young ^a   Jeong, Hoon Jae ^a   Kim, Dae Won ^a   Kim, Mi Jin ^a   An, Jae Jin ^a   Sohn, Eun Jeong ^a   Kang, Hye Won ^a   Shin, Min Jea ^a   Ahn, Eun Hee ^a   Kwon, Soon Won ^a   Kim, Duk Soo ^b   Cho, Sung Woo ^c   Park, Jinseu ^a   Eum, Won Sik ^a   Choi, Soo Young ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Cytokines; Inflammation; Mitogen activated protein kinase; NF B; PEP 1 FK506BP; Protein therapy

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYTOKINE; FK 506 BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEP 1 FK506BP; PREDNISOLONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SKIN INFLAMMATION;

ANIMALS; CELL LINE; CYCLOOXYGENASE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MICE, INBRED ICR; MODELS, ANIMAL; NF-KAPPA B; SIGNAL TRANSDUCTION; SKIN DISEASES; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSDUCTION, GENETIC;

EID: 79957602694     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.12.008     Document Type: Article

References (49)

1. An J.J., Lee Y.P., Kim S.Y., Lee S.H., Lee M.J., Jeong M.S., Kim D.W., Jang S.H., Yoo K.Y., Won M.H., Kang T.C., Kwon O.S., Cho S.W., Lee K.S., Park J., Eum W.S., Choi S.Y. Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J. 2008, 275:1296-1308.
2. Balkwill F., Coussens L.M. Cancer: an inflammatory link. Nature 2004, 431:405-406.
3. Baud V., Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 2009, 8:33-40.
4. Bertolini A., Ottani A., Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem. 2002, 9:1033-1043.
5. Bradford M.A. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Breiman A., Camus I. The involvement of mammalian and plant FK506-binding proteins (FKBPs) in development. Transgenic Res. 2002, 11:321-335.
7. Cejka D., Hayer S., Niederreiter B., Sieghart W., Fuereder T., Zwerina J., Schett G. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheum. 2010, 62:2294-2302.
8. Cho H.J., Seon M.R., Lee Y.M., Kim J., Kim J.K., Kim S.G., Park J.H. 3,3'-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophage. J. Nutr. 2008, 138:17-23.
9. Choi H.S., An J.J., Kim S.Y., Lee S.H., Kim D.W., Yoo K.Y., Won M.H., Kang T.C., Kwon H.J., Kang J.H., Cho S.W., Kwon O.S., Park J., Eum W.S., Choi S.Y. PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic. Biol. Med. 2006, 41:1058-1068.
10. Choi S.H., Kim S.Y., An J.J., Lee S.H., Kim D.W., Ryu H.J., Lee N.I., Yeo S.I., Jang S.H., Won M.H., Kang T.C., Kwon H.J., Cho S.W., Kim J., Lee K.S., Park J., Eum W.S., Choi S.Y. Human PEP-1-ribosomal protein S3 protects against UV-induced skin cell death. FEBS Lett. 2006, 580:6755-6762.
11. Chung W.Y., Park J.H., Kim M.J., Kim H.O., Hwang J.K., Lee S.K., Park K.K. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kB. Carcinogenesis 2007, 28:1224-1231.
12. De Vry C.G., Valdez M., Lazarov M., Muhr E., Buelow R., Fong T., Iyer S. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J. Invest. Dermatol. 2005, 125:473-481.
13. Dhar A., Young M.R., Colburn N.H. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem. 2002, 234-235:185-193.
14. Dubois S., Shou W., Haneline L.S., Fleischer S., Waldmann T.A., Muller J.R. Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T-cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14169-14174.
15. Eum W.S., Kim D.W., Hwang I.K., Yoo K.Y., Kang T.C., Jang S.H., Choi H.S., Choi S.H., Kim Y.H., Kim S.Y., Kwon H.Y., Kang J.H., Kwon O.S., Cho S.W., Lee K.S., Park J., Won M.H., Choi S.Y. In vivo protein transduction: biologically active intact PEP-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 2004, 37:1656-1669.
16. Faivre S., Kroemer G., Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 2006, 5:671-688.
17. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
18. Franco L., Doria D., Bertazzoni E., Benini A., Bassi C. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. Prostaglandins Other Lipid Mediat. 2004, 73:51-58.
19. Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-target-functions. Curr. Top. Med. Chem. 2003, 3:1315-1347.
20. Guo X., Dillman J.F., Dawwon V.L., Dawson T.M. Neuroimmune-philins novel neuroprotective and neuroregenerative targets. Ann. Neurol. 2001, 50:6-16.
21. Ha H.Y., Kim Y., Ryoo Z.Y., Kim T.Y. Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD. Biochem. Biophys. Res. Commun. 2006, 348:450-458.
22. Harrar Y., Bellini C., Faure J.D. FKBPs: at the crossroads of folding and transduction. Trends Plant Sci. 2001, 6:426-431.
23. Ho Y.S., Lai C.S., Liu H.I., Ho S.Y., Tai C., Pan M.H., Wang Y.J. Dihydrolipoic acid inhibits skin tumor promotion through anti-inflammation and anti-oxidation. Biochem. Pharmacol. 2007, 73:1786-1795.
24. Kang C.B., Ye H., Dhe-Paganon S., Yoon H.S. FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 2008, 16:318-325.
25. Korhonen R., Lathi A., Kankaanranta H., Moilanen E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 2005, 4:471-479.
26. Kundu J.K., Shin Y.K., Surh Y.J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem. Pharmacol. 2006, 72:1506-1515.
27. Kundu J.K., Surh Y.J. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. Mutat. Res. 2005, 591:123-146.
28. Lai C.S., Li S., Chai C.Y., Lo C.Y., Dushenkov S., Ho C.T., Pan M.H., Wang Y.J. Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin. Carcinogenesis 2008, 29:2415-2424.
29. Lai C.S., Li S., Chai C.Y., Lo C.Y., Ho C.T., Wang Y.J., Pan M.H. Inhibitory effect of citrus 5-hydrxoy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 2007, 28:2581-2588.
30. Lawrence T., Gilroy D.W., Colville-Nash P.R., Willoughby D.A. Possible new role for NF-kB in the resolution of inflammation. Nat. Med. 2001, 7:1291-1297.
31. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2000, 105:1135-1143.
32. Lim H., Son K.H., Chang H.W., Kang S.S., Kim H.P. Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation. Biol. Pharm. Bull. 2006, 29:1046-1049.
33. Long C., Cook L.G., Hamilton S.L., Wu G.Y., Mitchell B.M. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension 2007, 49:569-576.
34. Mararov S.S. NF-kB as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Today 2000, 6:441-448.
35. Medeiros R., Otuki M.F., Avellar M.C., Calixto J.B. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amylin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Eur. J. Pharmacol. 2007, 559:227-235.
36. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 2001, 19:1173-1176.
37. Murakawa M., Yamaoka K., Tanaka Y., Fukuda Y. Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice. Biochem. Pharmacol. 2006, 71:1331-1336.
38. Nakamura H., Aoki M., Tamai K., Oishi M., Ogihara T., Kaneda Y., Morishita R. Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther. 2002, 9:1221-1229.
39. Osman B., Akool E.S., Doller A., Muller R., Pfeilschifter J., Eberhardt W. Differential modulation of the cytokine-induced MMP-9/TIMP-1 protease-antiprotease system by the mTOR inhibitor rapamycin. Biochem. Pharmacol. 2011, 81:134-143.
40. Schiene-Fischer C., Yu C. Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerase. FEBS Lett. 2001, 495:1-6.
41. Song H.Y., Lee J.A., Ju S.M., Yoo K.Y., Won M.H., Kwon H.J., Eum W.S., Jang S.H., Choi S.Y., Park J. Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochem. Pharmacol. 2008, 75:1348-1357.
42. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3:768-780.
43. Tilley S.L., Coffman T.M., Koller B.A. Mixed message gene: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 2001, 107:191-195.
44. Uto T., Suangkaew N., Morinaga O., Kariyazono H., Oiso S., Shoyama Y. Eriobotryae folium extract suppresses LPS-induced iNOS and COX-2 expression by inhibition of NF-kappaB and MAPK activation in murine macrophages. Am. J. Chin. Med. 2010, 38:985-994.
45. Wadia J., Dowdy S.F. Protein transduction technology. Curr. Opin. Biotechnol. 2002, 13:52-56.
46. Wang T., Donahoe P.K. The immunophilin FKBP12: a molecular guardian of the TGF-β family type I receptors. Front Biosci. 2004, 9:619-631.
47. Yamaguchi T., Kurisaki A., Yamakawa N., Minakuchi K., Sugino H. FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on active type I receptor. J. Mol. Endocrinol. 2006, 36:569-579.
48. Yamamoto Y., Gaynor R.B. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 2004, 29:72-79.
49. Yun K.J., Kim J.Y., Kim J.B., Lee K.W., Jeong S.Y., Park H.J., Jung H.J., Cho Y.W., Yun K., Lee K.T. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in Raw 264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int. Immunopharmacol. 2008, 8:431-441.